High-Dose Flu Shot Linked to 55% Lower Alzheimer's Risk in Adults 65 and Up
Updated
Updated · Prevention Magazine · Jun 20
High-Dose Flu Shot Linked to 55% Lower Alzheimer's Risk in Adults 65 and Up
1 articles · Updated · Prevention Magazine · Jun 20
Summary
About 165,000 older adults were analyzed in a Neurology study, which found those receiving a high-dose flu vaccine had nearly 55% lower Alzheimer’s risk over two years than standard-dose recipients.
The high-dose shot contains four times the antigen of a standard flu vaccine, and researchers and outside experts said stronger protection against infection and inflammation could help explain the association.
The study showed correlation, not proof of prevention, and experts said healthier people may also be more likely to keep up with vaccinations, potentially influencing the result.
Earlier work by the same team found a standard-dose flu shot was tied to a 40% lower Alzheimer’s risk over four years, while other adult vaccines were also associated with lower risk.
CDC guidance already recommends high-dose flu vaccines for adults 65 and older, though experts said vaccination should be viewed as one part of broader brain-health measures.
Why might flu vaccines offer stronger Alzheimer's protection for women than for men?
Is the vaccine itself protecting the brain, or do healthier people just get vaccinated more often?
Could harnessing the immune system with targeted vaccines become the future of Alzheimer's prevention?
High-Dose Flu Vaccine Cuts Alzheimer’s Risk by 55% in Older Adults: New Evidence, Mechanisms, and Public Health Implications
Overview
A major study from UTHealth Houston found that older adults who received a high-dose flu vaccine had a 55% lower risk of developing Alzheimer’s disease compared to those who got the standard dose. Using a retrospective cohort design, researchers analyzed existing data to uncover this strong association, highlighting a promising new way to help prevent or delay Alzheimer’s. The study focused on older adults, who are especially vulnerable to both severe flu and Alzheimer’s, and showed that analyzing health data over time can reveal important links between specific exposures, like vaccines, and health outcomes. This breakthrough could shape future prevention strategies.